Construction of a knockout targeting vector to generate an Interleukin-13 Receptor α1 deficient Balb/c mouse

Research Projects

Organizational Units

Journal Issue

Abstract

A recent publication from our lab has provided evidence for the involvement of the α1 chain of the Interleukin-13 cytokine receptor (IL-13Rα1) in the development of the neonatal immune system. Specifically, we have shown that cell death of T helper type 1 (Th1) effector cells can be prevented by antibody-mediated blockade of IL-13Rα1. Currently, a knockout mouse deficient in expression of IL-13Rα1 is not available and the development of an IL-13Rα1 knockout mouse will provide new insights on the relationship between IL-13Rα1 signaling and neonatal immunity. In this effort we have begun construction of a targeting vector that will bear sufficient homology to the IL-13Rα1 wild-type locus to allow for deletion of exons 7, 8, and 9 via homologous recombination, thereby rendering that allele non-functional. After construction of the targeting vector, a collaborative effort between the Transgenic Animal Core facility here at the University of Missouri will continue throughout the remainder of the cell culture, embryonic manipulation, and screening processes.

Table of Contents

DOI

PubMed ID

Degree

Thesis Department

Rights

License